title: Fasting hyperglycemia predicts the magnitude of postprandial hyperglycemia: implications for diabetes therapy.
authors.forename: Mary F
authors.initials: MF
authors.lastname: Carroll
authors.forename: Ahmad
authors.initials: A
authors.lastname: Izard
authors.forename: Katrina
authors.initials: K
authors.lastname: Riboni
authors.forename: Mark R
authors.initials: MR
authors.lastname: Burge
authors.forename: David S
authors.initials: DS
authors.lastname: Schade
mesh_terms: D000284:Administration, Oral; D003920:Diabetes Mellitus / Q000097:blood*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood*; D005215:Fasting; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism*; D006801:Humans; D006943:Hyperglycemia / Q000503:physiopathology*; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008297:Male; D009765:Obesity; D019518:Postprandial Period; D011237:Predictive Value of Tests
chemical_list: D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents